Investors Shouldn't Be Too Comfortable With Neuren Pharmaceuticals' (ASX:NEU) Earnings
Sep 02
Have your own idea? Try our Stock Screener
Australian (ASX) Healthcare Sector Analysis
UpdatedSep 02, 2025
DataAggregated Company Financials
Companies129
- 7D-1.6%
- 3M-6.3%
- 1Y-15.2%
- YTD-12.1%
Over the last 7 days, the Healthcare industry has dropped 1.6%, driven by a pullback from CSL of 3.2%. In contrast, Sigma Healthcare has gained 9.6%. The industry has fallen 15% in the last year. Looking forward, earnings are forecast to grow by 17% annually.
Sector Valuation and Performance
Has the Australian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 02 Sep 2025 | AU$242.8b | AU$74.8b | AU$4.6b | 32.3x | 53x | 3.2x |
| Thu, 31 Jul 2025 | AU$277.8b | AU$71.8b | AU$4.3b | 31x | 64.6x | 3.9x |
| Sat, 28 Jun 2025 | AU$251.4b | AU$71.7b | AU$4.3b | 26x | 59x | 3.5x |
| Mon, 26 May 2025 | AU$257.5b | AU$71.8b | AU$4.3b | 27.4x | 60.3x | 3.6x |
| Wed, 23 Apr 2025 | AU$239.5b | AU$70.7b | AU$4.9b | 26.7x | 48.9x | 3.4x |
| Fri, 21 Mar 2025 | AU$258.1b | AU$71.2b | AU$4.9b | 28.3x | 52.4x | 3.6x |
| Sun, 16 Feb 2025 | AU$239.0b | AU$66.0b | AU$3.6b | 28.8x | 67.3x | 3.6x |
| Tue, 14 Jan 2025 | AU$245.6b | AU$66.6b | AU$3.3b | 23.3x | 74.3x | 3.7x |
| Thu, 12 Dec 2024 | AU$244.3b | AU$68.6b | AU$3.3b | 26.6x | 74.1x | 3.6x |
| Sat, 09 Nov 2024 | AU$242.2b | AU$67.5b | AU$3.1b | 25.5x | 77.4x | 3.6x |
| Mon, 07 Oct 2024 | AU$241.0b | AU$66.9b | AU$3.0b | 30.4x | 79.4x | 3.6x |
| Wed, 04 Sep 2024 | AU$243.3b | AU$66.2b | AU$3.1b | 27.4x | 79x | 3.7x |
| Fri, 02 Aug 2024 | AU$246.9b | AU$63.2b | AU$2.7b | 29.7x | 91.7x | 3.9x |
| Sun, 30 Jun 2024 | AU$237.4b | AU$62.7b | AU$2.6b | 32.1x | 90.8x | 3.8x |
| Tue, 28 May 2024 | AU$224.3b | AU$61.1b | AU$2.6b | 27.7x | 85.9x | 3.7x |
| Thu, 25 Apr 2024 | AU$222.5b | AU$61.6b | AU$2.7b | 26.7x | 82.8x | 3.6x |
| Sat, 23 Mar 2024 | AU$222.2b | AU$61.8b | AU$2.7b | 26.2x | 83x | 3.6x |
| Mon, 19 Feb 2024 | AU$223.4b | AU$60.5b | AU$3.5b | 25.8x | 64.2x | 3.7x |
| Wed, 17 Jan 2024 | AU$222.5b | AU$60.4b | AU$2.8b | 24.6x | 78.4x | 3.7x |
| Fri, 15 Dec 2023 | AU$215.2b | AU$60.0b | AU$2.8b | 24.9x | 76.8x | 3.6x |
| Sun, 12 Nov 2023 | AU$200.5b | AU$61.2b | AU$3.0b | 24.5x | 67.1x | 3.3x |
| Tue, 10 Oct 2023 | AU$200.5b | AU$61.3b | AU$2.9b | 24.9x | 68.1x | 3.3x |
| Thu, 07 Sep 2023 | AU$210.8b | AU$61.3b | AU$2.9b | 26.6x | 72.5x | 3.4x |
| Sat, 05 Aug 2023 | AU$210.2b | AU$58.1b | AU$2.9b | 26.1x | 71.3x | 3.6x |
| Mon, 03 Jul 2023 | AU$216.5b | AU$57.8b | AU$2.9b | 27x | 74.8x | 3.7x |
| Wed, 31 May 2023 | AU$231.9b | AU$58.1b | AU$2.9b | 26.7x | 78.9x | 4x |
| Fri, 28 Apr 2023 | AU$232.7b | AU$57.4b | AU$2.9b | 28.2x | 80.3x | 4.1x |
| Sun, 26 Mar 2023 | AU$220.6b | AU$57.2b | AU$2.9b | 24.9x | 76.7x | 3.9x |
| Tue, 21 Feb 2023 | AU$225.5b | AU$56.1b | AU$3.3b | 24.9x | 68.2x | 4x |
| Thu, 19 Jan 2023 | AU$223.6b | AU$55.0b | AU$3.9b | 25.5x | 56.6x | 4.1x |
| Sat, 17 Dec 2022 | AU$219.6b | AU$55.9b | AU$4.1b | 25.1x | 53.7x | 3.9x |
| Mon, 14 Nov 2022 | AU$222.2b | AU$55.7b | AU$4.1b | 26.2x | 54.5x | 4x |
| Wed, 12 Oct 2022 | AU$211.2b | AU$56.8b | AU$4.3b | 28.9x | 49.4x | 3.7x |
| Fri, 09 Sep 2022 | AU$226.4b | AU$55.4b | AU$4.1b | 25.4x | 55.3x | 4.1x |
Price to Earnings Ratio
55.3x
Current Industry PE
- Investors are pessimistic on the Australian Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 53.0x which is lower than its 3-year average PE of 70.3x.
- The 3-year average PS ratio of 3.7x is higher than the industry's current PS ratio of 3.2x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 3.8% per year over the last three years.
- Revenues for these companies have grown 11% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Australian Healthcare sector?
| AU Market | -0.41% | |
| Healthcare | -1.57% | |
| Healthcare Services | 2.82% | |
| Medical Equipment | 0.057% | |
| Healthtech | -1.22% | |
| Pharma | -2.05% | |
| Biotech | -4.26% | |
| Life Sciences | -5.86% | |
Industry PE
- Investors are most optimistic about the Medical Equipment industry even though it's trading below its 3-year average PE ratio of 207x.
- Analysts are expecting annual earnings growth of 17.1%, which is lower than the prior year's growth of 24.7% per year.
Forecasted Growth
- Analysts are most optimistic on the Life Sciences industry, expecting annual earnings growth of 69% over the next 5 years.
- This is better than its past earnings decline of 0.5% per year.
- In contrast, the Biotech industry is expected to see its earnings grow by 15% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| SIG Sigma Healthcare | AU$3.09 | 9.6% +AU$3.1b | n/a | PE67.1x | |
| NEU Neuren Pharmaceuticals | AU$19.61 | 10.2% +AU$230.4m | 39.4% | PE16.6x | |
| PNV PolyNovo | AU$1.45 | 14.6% +AU$127.8m | -39.8% | PE75.8x | |
| 4DX 4DMedical | AU$0.77 | 41.3% +AU$104.8m | 79.1% | PS61.2x | |
| IMR Imricor Medical Systems | AU$1.43 | 6.3% +AU$27.2m | 161.5% | PS397.1x |
